nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—CHRM3—nephrolithiasis	0.948	1	CbGaD
Carbachol—CHRM3—ureter—nephrolithiasis	0.0114	0.708	CbGeAlD
Carbachol—Bethanechol—CHRM3—nephrolithiasis	0.00498	0.591	CrCbGaD
Carbachol—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00372	0.174	CbGpPWpGaD
Carbachol—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00367	0.172	CbGpPWpGaD
Carbachol—Succinylcholine—CHRM3—nephrolithiasis	0.00345	0.409	CrCbGaD
Carbachol—PLA2G4A—renal system—nephrolithiasis	0.00151	0.0937	CbGeAlD
Carbachol—PLA2G4A—cortex of kidney—nephrolithiasis	0.00142	0.0882	CbGeAlD
Carbachol—CHRM3—renal system—nephrolithiasis	0.000905	0.0563	CbGeAlD
Carbachol—CHRM3—kidney—nephrolithiasis	0.000875	0.0544	CbGeAlD
Carbachol—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.000822	0.0385	CbGpPWpGaD
Carbachol—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.000811	0.038	CbGpPWpGaD
Carbachol—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000691	0.0324	CbGpPWpGaD
Carbachol—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000682	0.032	CbGpPWpGaD
Carbachol—Stinging—Hydrochlorothiazide—nephrolithiasis	0.000633	0.11	CcSEcCtD
Carbachol—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.000504	0.0877	CcSEcCtD
Carbachol—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000504	0.0236	CbGpPWpGaD
Carbachol—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000502	0.0235	CbGpPWpGaD
Carbachol—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000497	0.0233	CbGpPWpGaD
Carbachol—PLA2G4A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.000413	0.0194	CbGpPWpGaD
Carbachol—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000374	0.065	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.000373	0.0648	CcSEcCtD
Carbachol—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.00036	0.0169	CbGpPWpGaD
Carbachol—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000345	0.0162	CbGpPWpGaD
Carbachol—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.000335	0.0583	CcSEcCtD
Carbachol—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000284	0.0133	CbGpPWpGaD
Carbachol—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000283	0.0133	CbGpPWpGaD
Carbachol—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000275	0.0478	CcSEcCtD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000254	0.0119	CbGpPWpGaD
Carbachol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000253	0.0119	CbGpPWpGaD
Carbachol—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000246	0.0115	CbGpPWpGaD
Carbachol—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000246	0.0115	CbGpPWpGaD
Carbachol—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000243	0.0114	CbGpPWpGaD
Carbachol—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000243	0.0114	CbGpPWpGaD
Carbachol—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000239	0.0416	CcSEcCtD
Carbachol—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00023	0.04	CcSEcCtD
Carbachol—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000221	0.0384	CcSEcCtD
Carbachol—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000216	0.0375	CcSEcCtD
Carbachol—PLA2G4A—Hemostasis—DGKH—nephrolithiasis	0.000213	0.00998	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—SLC7A9—nephrolithiasis	0.000213	0.00998	CbGpPWpGaD
Carbachol—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000205	0.00962	CbGpPWpGaD
Carbachol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000201	0.035	CcSEcCtD
Carbachol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000197	0.0343	CcSEcCtD
Carbachol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000184	0.0086	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—RGS14—nephrolithiasis	0.000181	0.00848	CbGpPWpGaD
Carbachol—Shock—Hydrochlorothiazide—nephrolithiasis	0.00018	0.0313	CcSEcCtD
Carbachol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000177	0.0308	CcSEcCtD
Carbachol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000171	0.0297	CcSEcCtD
Carbachol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000161	0.028	CcSEcCtD
Carbachol—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000159	0.00743	CbGpPWpGaD
Carbachol—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000157	0.00734	CbGpPWpGaD
Carbachol—Pain—Hydrochlorothiazide—nephrolithiasis	0.000157	0.0272	CcSEcCtD
Carbachol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000145	0.0252	CcSEcCtD
Carbachol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000145	0.0252	CcSEcCtD
Carbachol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000136	0.00637	CbGpPWpGaD
Carbachol—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000134	0.00629	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—GRHPR—nephrolithiasis	0.000128	0.00599	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ADCY10—nephrolithiasis	0.000126	0.00589	CbGpPWpGaD
Carbachol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000125	0.0218	CcSEcCtD
Carbachol—PLA2G4A—Signaling by GPCR—DGKH—nephrolithiasis	0.000122	0.00573	CbGpPWpGaD
Carbachol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000121	0.021	CcSEcCtD
Carbachol—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00012	0.00561	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000119	0.00559	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000118	0.00554	CbGpPWpGaD
Carbachol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000116	0.0202	CcSEcCtD
Carbachol—Rash—Hydrochlorothiazide—nephrolithiasis	0.000115	0.0201	CcSEcCtD
Carbachol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000115	0.0201	CcSEcCtD
Carbachol—Headache—Hydrochlorothiazide—nephrolithiasis	0.000115	0.0199	CcSEcCtD
Carbachol—PLA2G4A—Metabolism—AGXT—nephrolithiasis	0.000114	0.00534	CbGpPWpGaD
Carbachol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000109	0.0189	CcSEcCtD
Carbachol—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.000109	0.0051	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000108	0.00508	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000107	0.00503	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RGS14—nephrolithiasis	0.000107	0.00501	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000103	0.00485	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000102	0.00479	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—SLC26A1—nephrolithiasis	9.69e-05	0.00454	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—APRT—nephrolithiasis	9.69e-05	0.00454	CbGpPWpGaD
Carbachol—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	9.47e-05	0.00444	CbGpPWpGaD
Carbachol—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	9.44e-05	0.00442	CbGpPWpGaD
Carbachol—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	9.34e-05	0.00438	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—CHRM3—nephrolithiasis	8.84e-05	0.00414	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	8.09e-05	0.00379	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—PTH—nephrolithiasis	8.08e-05	0.00379	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	8.06e-05	0.00378	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	7.99e-05	0.00374	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GRHPR—nephrolithiasis	7.66e-05	0.00359	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	7.56e-05	0.00354	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	7.53e-05	0.00353	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	7.46e-05	0.0035	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	7.35e-05	0.00344	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	7.32e-05	0.00343	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	7.25e-05	0.0034	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.22e-05	0.00338	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—DGKH—nephrolithiasis	7.22e-05	0.00338	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AQP1—nephrolithiasis	6.9e-05	0.00324	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AGXT—nephrolithiasis	6.83e-05	0.0032	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	6.42e-05	0.00301	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	6.4e-05	0.003	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	6.34e-05	0.00297	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—CHRM3—nephrolithiasis	6.24e-05	0.00293	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	5.85e-05	0.00274	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—APRT—nephrolithiasis	5.8e-05	0.00272	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—SLC26A1—nephrolithiasis	5.8e-05	0.00272	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	5.77e-05	0.00271	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	5.35e-05	0.00251	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	5.33e-05	0.0025	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	5.31e-05	0.00249	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	5.28e-05	0.00247	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	5.24e-05	0.00246	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CHRM3—nephrolithiasis	5.22e-05	0.00245	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	4.86e-05	0.00228	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	4.84e-05	0.00227	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	4.8e-05	0.00225	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PTH—nephrolithiasis	4.77e-05	0.00224	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	4.34e-05	0.00203	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.34e-05	0.00203	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.33e-05	0.00203	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	4.33e-05	0.00203	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.28e-05	0.00201	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	4.28e-05	0.00201	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AQP1—nephrolithiasis	4.14e-05	0.00194	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	3.14e-05	0.00147	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	3.1e-05	0.00145	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTH—nephrolithiasis	2.87e-05	0.00134	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTH—nephrolithiasis	2.86e-05	0.00134	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTH—nephrolithiasis	2.83e-05	0.00133	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SPP1—nephrolithiasis	2.4e-05	0.00112	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.44e-05	0.000675	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.44e-05	0.000673	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.42e-05	0.000666	CbGpPWpGaD
